Pila PR, Pila PR, Holguín PVA, Torres VE, Rodríguez MM

Language: Spanish
References: 15
Page: 301-311
PDF size: 351.98 Kb.

ABSTRACT

Background: polyglandular autoimmune syndrome type II is a clinical rarity; among all variants this syndrome is the most common. It is mainly characterized by the presence of autoimmune Addison´s disease combined with autoimmune thyroiditis and type I diabetes mellitus. This syndrome appears around the third and fourth decades of life. It is more frequent in women than in men, in a ratio of 3-4:1.
Objective: to present a clinical case of Schmidt-Carpenter syndrome.
Clinical Case: a thirty-five-year-old female patient who presented type I diabetes mellitus at the age of 20 and nine years later a Hashimoto´s thyroiditis. In the last five years the patient presented amenorrhea alternated with metrorrhagia and had three miscarriages. After her hospital admission, it was established alopecia and a symptomatic complex compatible with adrenal insufficiency. Clinical and analytical studies confirmed the presence of Shmidt-Carpenter syndrome associated with hypogonadism and alopecia.
Conclusions: this syndrome is a rare and severe disease that affects multiple endocrine glands caused by immune disorders with destruction of tissues. The diagnosis is clinical, confirmed by the establishment of hormonal levels and immunity tests. This syndrome should be differentiated from other immune, chromosomal, hematological, and digestive processes that affect other glands and organs. The therapeutics employed was effective. This disease is relevant to clinical specialties, particularly for internal medicine, endocrinology, immunology, and genetics.

REFERENCES

1. Pourmotabbed G, Talavera F, Chausmer AB, Cooper M, Griffing GT, editors. Polyglandular Autoimmune Syndrome, Type II [Internet]. New York: www.emedicine.com; 2012 [cited 2011 Jun 15]. Available from: http://emedicine.medscape.com/article/124287-overview

2. Kronenberg HM. Polyglandular disorders. In: Goldman L, Schafer AI, editors. Goldman’s Cecil Medicine. 24th ed. Philadelphia: Saunders Elsevier; 2012. p. 1505-09.

3. Betterle C, Lazzarotto F, Presotto F. Autoimmune polyglandular syndrome Type 2: the tip of an iceberg? Clin Exp Immunol. 2004 Aug;137(2):225-33.

4. Gagel RF, Jimenez C. Disorders Affecting Multiple Endocrine Systems. In: Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine [CD-ROM]. 18th ed. New York: McGraw-Hill; 2012.

5. Karamifar H, Dalili S, Karamizadeh Z, Amirhakimi G, Dalili H. Autoimmune polyglandular syndrome type 2: an unusual presentation. Acta Med Iran. 2010 May-Jun;48(3):196-7.

6. Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. J Clin Endocrinol Metab. 2003 Jul;88(7):2983-92.

7. Carpenter C, Solomon N, Silverberg SG, Bledsoe T, Northcutt RC, Klinenberg JR, et al. Schmidt’s syndrome (thyroid ans adrenal insufficiency): a review of the literature and a report of fifteen new cases including ten instances of co-existent diabetes mellitus. Medicine (Baltimore). 1964 Mar;43:153-80.

8. Gumieniak O, Farwell AP. Schmidt'S syndrome and severe hyponatremia: report of an unusual case and review of the related literature. Endocr Pract. 2003 Sep-Oct;9(5):384-8.

9. Locher R, Kohler S, Schwanda S, Schmid C. Tiredness, hyperpigmentation, weight loss, nausea and vomiting. Polyglandular autoimmune syndrome (PAS) type 2. Praxis (Bern 1994). 2010 Oct 6;99(20):1223-8.

10. Bizzaro N. The predictive significance of autoantibodies in organ-specific autoimmune diseases. Clin Rev Allergy Immunol. 2008 Jun;34(3):326-31.

11. de Graaff LC, Smit JW, Radder JK. Prevalence and clinical significance of organ-specific autoantibodies in type 1 diabetes mellitus. Neth J Med. 2007 Jul-Aug;65(7):235-47.

12. Kauffman RP, Castracane VD. Premature ovarian failure associated with autoimmune polyglandular syndrome: pathophysiological mechanisms and future fertility. J Womens Health (Larchmt). 2003 Jun;12(5):513-20.

13. Wellons M. Cardiovascular Disease and Primary Ovarian Insufficiency. Semin Reprod Med. 2011 Jul;29(4):328-41.

14. Krysiak R, Boldys A, Okopien B. Autoimmune polyglandular syndrome type 2 induced by treatment with interferon alpha. Am J Med Sci. 2011 Jun;341(6):504-7.

15. Watanabe S, Tanaka J, Ohta T, Yoshizawa H, Gejyo F. Paraneoplastic neurological syndrome and polyglandular autoimmune syndrome type 2 in a case of small cell lung cancer. Thorax. 2008 Dec;63(12):1118-9.